Pentazocine 363Brogden, R.N., T.M. Speight, and G.S. Avery. “Pentazocine: A Review of Its Pharma-
cological Properties, Therapeutic Efficacy and Dependence Liability.”Drugs 5
(1973): 6–91.
Debooy, V.D., et al. “Intravenous Pentazocine and Methylphenidate Abuse during
Pregnancy. Maternal Lifestyle and Infant Outcome.”American Journal of Diseases
of Children147 (1993): 1062–65.
“Pentazocine.”British Medical Journal2 (1970):409–10.
Saarialho-Kere, U., M.J. Mattila, and T. Seppala. “Parenteral Pentazocine: Effects on
Psychomotor Skills and Respiration, and Interactions with Amitriptyline.”Eu-
ropean Journal of Clinical Pharmacology35 (1988): 483–89.
Showalter, C.V. “T’s and Blues: Abuse of Pentazocine and Tripelennamine.”Journal of
the American Medical Association244 (1980): 1224–25.
Zacny, J.P., et al. “Comparing the Subjective, Psychomotor and Physiological Effects of
Intravenous Pentazocine and Morphine in Normal Volunteers.”Journal of Phar-
macology and Experimental Therapeutics286 (1998): 1197–207.